Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
ripretinib | serine/threonine-protein kinase b-raf | small molecule | NA | drugbank | Diagnosis[MeSHID:D003933] Gastrointestinal Stromal Tumors[MeSHID:D046152] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Glioma[MeSHID:D005910] Malignant Neoplasms[MeSHID:D009369] Mastocytosis Systemic[MeSHID:D034721] |
NA | approved | inhibitor |
ripretinib | vascular endothelial growth factor receptor 2 | small molecule | NA | drugbank | Diagnosis[MeSHID:D003933] Gastrointestinal Stromal Tumors[MeSHID:D046152] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Glioma[MeSHID:D005910] Malignant Neoplasms[MeSHID:D009369] Mastocytosis Systemic[MeSHID:D034721] |
NA | approved | inhibitor |
ripretinib | tyrosine-protein kinase kit | NA | Successful target | TTD , DGIDB | Diagnosis[MeSHID:D003933] Gastrointestinal Stromal Tumors[MeSHID:D046152] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Glioma[MeSHID:D005910] Malignant Neoplasms[MeSHID:D009369] Mastocytosis Systemic[MeSHID:D034721] |
2.21 | approved | inhibitor |
ripretinib | mast/stem cell growth factor receptor kit | small molecule | NA | drugbank , DGIDB | Diagnosis[MeSHID:D003933] Gastrointestinal Stromal Tumors[MeSHID:D046152] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Glioma[MeSHID:D005910] Malignant Neoplasms[MeSHID:D009369] Mastocytosis Systemic[MeSHID:D034721] |
2.21 | approved | inhibitor |
ripretinib | platelet-derived growth factor receptor alpha | small molecule | Successful target | TTD , drugbank | Diagnosis[MeSHID:D003933] Gastrointestinal Stromal Tumors[MeSHID:D046152] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Glioma[MeSHID:D005910] Malignant Neoplasms[MeSHID:D009369] Mastocytosis Systemic[MeSHID:D034721] |
NA | approved | inhibitor |
ripretinib | platelet-derived growth factor receptor beta | small molecule | NA | drugbank | Diagnosis[MeSHID:D003933] Gastrointestinal Stromal Tumors[MeSHID:D046152] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Glioma[MeSHID:D005910] Malignant Neoplasms[MeSHID:D009369] Mastocytosis Systemic[MeSHID:D034721] |
NA | approved | inhibitor |
ripretinib | angiopoietin-1 receptor | small molecule | NA | drugbank | Diagnosis[MeSHID:D003933] Gastrointestinal Stromal Tumors[MeSHID:D046152] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Glioma[MeSHID:D005910] Malignant Neoplasms[MeSHID:D009369] Mastocytosis Systemic[MeSHID:D034721] |
NA | approved | inhibitor |
click here to return to the previous page |